Información del artículo
El Texto completo está disponible en PDF
Bibliografía
[1.]
D. VanderHeijde, S. VanderLinden, N. Bellamy, A. Calin, M. Dougados, M.A. Khan.
Which domains should be included in a core set for endpoints in ankylosing spondylitis? Introduction to the ankylosing spondylitis module of OMERACT IV.
J Rheumatol, 26 (1999), pp. 945-947
[2.]
D. VanderHeijde, A. Calin, M. Dougados, M.A. Khan, S. VanderLinden, N. Bellamy.
Selection of instruments in the core set for DC-ART, SMARD, physical therapy, and clinical record keeping in ankylosing spondylitis. Progress report of the ASAS Working Group. Assessments in Ankylosing Spondylitis.
J Rheumatol, 26 (1999), pp. 951-954
[3.]
R. Ariza-Ariza, B. Hérnandez-Cruz, F. Navarro-Sarabia.
Physical function and health-related quality of life of Spanish patients with ankylosing spondylitis.
Arthritis Rheum, 49 (2003), pp. 483-487
[4.]
R. Ariza-Ariza, B. Hernández-Cruz, F. Navarro-Sarabia.
La versión española del BASDAI es fiable y se correlaciona con la actividad de la enfermedad en pacientes con espondilitis anquilosante.
Rev Esp Reumatol, 31 (2004), pp. 372-378
[5.]
P. Zarco.
Valoración de la actividad, respuesta al tratamiento y criterios de refractariedad en espondiloartropatías.
Rev Esp Reumatol, 28 (2001), pp. 387-394
[6.]
J.J. Anderson, G. Baron, D. Van der Heijde, D.T. Felson, M. Dougados.
Ankylosing spondylitis assessment group preliminary definition of shortterm improvement in ankylosing spondylitis.
Arthritis Rheum, 44 (2001), pp. 1876-1886
[7.]
A. Van Tubergen, D. Van der Heijde, J. Anderson, R. Landewe, M. Dougados, J. Braun, et al.
Comparison of statistically derived ASAS improvement criteria for ankylosing spondylitis with clinically relevant improvement according to an expert panel.
Ann Rheum Dis, 62 (2003), pp. 215-221
[8.]
J. Brandt, J. Listing, J. Sieper, M. Rudwaleit, D. Van der Heijde, J. Braun.
Development and preselection of criteria for short term improvement after anti-TNF alpha treatment in ankylosing spondylitis.
Ann Rheum Dis, 63 (2004), pp. 1438-1444
[9.]
A.J. Wanders, J.D. Gorman, J.C. Davis, R.B. Landewe, D. Van der Heijde.
Responsiveness and discriminative capacity of the assessments in ankylosing spondylitis disease-controlling antirheumatic therapy core set and other outcome measures in a trial of etanercept in ankylosing spondylitis.
Arthritis Rheum, 51 (2004), pp. 1-8
[10.]
D. Van der Heijde, M. Dougados, J. Davis, M.H. Weisman, W. Maksymowych, J. Braun, Assessment in Ankylosing Spondylitis International Working Group, et al.
Assessment in Ankylosing Spondylitis International Working Group/Spondylitis Association of America recommendations for conducting clinical trials in ankylosing spondylitis.
Arthritis Rheum, 52 (2005), pp. 386-394
Copyright © 2005. Elsevier España S.L. Barcelona
